|
|
|
Company Name
|
Repligen Corp
|
|
Drug Name
|
SecreFlo (NDA)
|
|
Event Name
|
FDA panel to review SecreFlo for detection of pancreatic duct abnormalities
|
|
Event Date
|
05/31/2012
|
|
Outcome
|
FDA Advisory Committee meeting cancelled; Complete response letter expected
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|